Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Reversible Focal Hepatic Steatosis in Type 1 Diabetic Patients Treated With Intraperitoneal Insulin Implantable Pump Therapy

Laurent Meyer, MD, Jeremy Jeantroux, MD, Jean Pierre Riveline, MD, François Moreau, MD, Sophie Boivin, MD, Thomas Moser, MD, Michel Pinget, MD, Nathalie Jeandidier, MD, PHD

Diabetes Care 2008;31(6):e49

https://doi.org/10.2337/dc07-2393

Published: 01 June 2008

View article titled, Reversible Focal Hepatic Steatosis in Type 1 Diabetic Patients Treated With Intraperitoneal Insulin Implantable Pump Therapy

Journal Articles

Comparison of Antigenicity of Hoechst 21PH Insulin Using Either Implantable Intraperitoneal Pump or Subcutaneous External Pump Infusion in Type 1 Diabetic Patients

Nathalie Jeandidier, MD, PHD, Sylvie Boullu, MD, Marie-Sophie Busch-Brafin, Gerard Chabrier, MD, Rémy Sapin, Françoise Gasser, Michel Pinget, MD, PHD

Diabetes Care 2002;25(1):84–88

https://doi.org/10.2337/diacare.25.1.84

Published: 01 January 2002

View article titled, Comparison of Antigenicity of Hoechst 21PH Insulin Using Either Implantable Intraperitoneal Pump or Subcutaneous External Pump Infusion in Type 1 Diabetic Patients

Meeting Abstracts

Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.

V Lassmann-Vague, M SanMarco, P J LeJeune, C Alessis, P Vague, P Belicar

Diabetes Care 1998;21(11):2041–2044

https://doi.org/10.2337/diacare.21.11.2041

Published: 01 November 1998

View article titled, Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.

Journal Articles

Successful Treatment With Insulin Analog Lispro in IDDM With Delayed Absorption of Subcutaneously Applied Human Regular Insulin and Complicated Intraperitoneal Insulin Infusion: A case report

Matthias Meier, MD, Johann Brand, MD, Eberhard Standl, PHD, Oliver Schnell, MD

Diabetes Care 1998;21(7):1044–1045

https://doi.org/10.2337/diacare.21.7.1044

Published: 01 July 1998

View article titled, Successful Treatment With Insulin Analog Lispro in IDDM With Delayed Absorption of Subcutaneously Applied Human Regular Insulin and Complicated Intraperitoneal Insulin Infusion: A case report

Journal Articles

Acute Effects of Intraperitoneal Versus Subcutaneous Insulin Delivery on Glucose Homeostasis in Patients With NIDDM

David E Kelley, MD, Robert R Henry, MD, Steven V Edelman, MD, The Veterans Affairs Implantable Insulin Pump Study Group

Diabetes Care 1996;19(11):1237–1242

https://doi.org/10.2337/diacare.19.11.1237

Published: 01 November 1996

View article titled, Acute Effects of Intraperitoneal Versus Subcutaneous Insulin Delivery on Glucose Homeostasis in Patients With NIDDM

Journal Articles

Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps

Nathalie Jeandidier, MD, Jean-Louis Selam, MD, Eric Renard, MD, Bruno Guerci, MD, Veronique Lassman-Vague, MD, Laure Rocher, MD, Hélène Hanaire-Broutin, MD, The Evadiac Study Group

Diabetes Care 1996;19(7):780

https://doi.org/10.2337/diacare.19.7.780

Published: 01 July 1996

View article titled, Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps

Journal Articles

Five Cases off Hyperthyroidism in Type I Diabetic Patients Treated With Intraperitoneal Insulin Infusion

N Jeandidier, MD, S Boivin, MD, V Buckenmeyer, MD, R Sapin, PHD, M Pinget, PHD

Diabetes Care 1995;18(6):888–889

https://doi.org/10.2337/diacare.18.6.888

Published: 01 June 1995

View article titled, Five Cases off Hyperthyroidism in Type I Diabetic Patients Treated With Intraperitoneal Insulin Infusion

Journal Articles

Immunogenicity of Long-Term Intraperitoneal Insulin Administration With Implantable Programmable Pumps: Metabolic consequences

Véronique Lassmann-Vague, MD, Pauline Belicar, MD, Denis Raccah, MD, Bernard Vialettes, MD, Jean Claude Sodoyez, MD, Philippe Vague, MD

Diabetes Care 1995;18(4):498–503

https://doi.org/10.2337/diacare.18.4.498

Published: 01 April 1995

View article titled, Immunogenicity of Long-Term Intraperitoneal Insulin Administration With Implantable Programmable Pumps: Metabolic consequences

Journal Articles

Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter study

Hélène Hanaire-Broutin, MD, Christiane Broussolle, MD, Nathalie Jeandidier, MD, Eric Renard, MD, Bruno Guerci, MD, Marie-Joelle Haardt, MD, Veronique Lassmann-Vague, MD, The EVADIAC study group

Diabetes Care 1995;18(3):388–392

https://doi.org/10.2337/diacare.18.3.388

Published: 01 March 1995

View article titled, Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter study

Journal Articles

Intraperitoneal Insulin Absorption After Lona-Term Intraperitoneal Insulin Therapy

Marina Scavini, MD, Angela Pincelli, MD, Giovanna Petrella, MD, Gabriella Galimberti, MD, Philip G Zager, MD, Michiela Torri, MD, Guido Pozza, MD

Diabetes Care 1995;18(1):56–59

https://doi.org/10.2337/diacare.18.1.56

Published: 01 January 1995

View article titled, Intraperitoneal Insulin Absorption After Lona-Term Intraperitoneal Insulin Therapy

Journal Articles

Diagnostic Procedures for Catheter Malfunction in Programmable Impiantante Intraperitoneal Insulin Infusion Devices

Craig L Olsen, MD, Dee S Turner, RN, MSN, ANP, Mohamad Iravani, BS, Kenneth Waxman, MD, Jean-Louis Selam, MD, M Arthur Charles, MD, PHD

Diabetes Care 1995;18(1):70–76

https://doi.org/10.2337/diacare.18.1.70

Published: 01 January 1995

View article titled, Diagnostic Procedures for Catheter Malfunction in Programmable Impiantante Intraperitoneal Insulin Infusion Devices

Journal Articles

Intraperitoneal Insulin Delivery Decreases the Levels of Chylomicron Remnants in Patients With IDDM

Angeliki Georgopoulos, MD, Christopher D Saudek, MD

Diabetes Care 1994;17(11):1295–1299

https://doi.org/10.2337/diacare.17.11.1295

Published: 01 November 1994

View article titled, Intraperitoneal Insulin Delivery Decreases the Levels of Chylomicron Remnants in Patients With IDDM

Journal Articles

A Case of Diabetic Pregnancy Controlled With a Percutaneous Access Device for Intraperitoneal Insulin Infusion

Oliver Schnell, MD, Evelin Gerlach, MD, Barbara Hillebrand, MD, Helmut Walter, PHD, Eberhard Standl, PHD

Diabetes Care 1994;17(11):1354–1355

https://doi.org/10.2337/diacare.17.11.1354

Published: 01 November 1994

View article titled, A Case of Diabetic Pregnancy Controlled With a Percutaneous Access Device for Intraperitoneal Insulin Infusion

Journal Articles

Complications of the Pump Pocket May Represent a Significant Cause of Incidents With Implanted Systems for Intraperitoneal Insulin Delivery

Eric Renard, MD, Jacques Bringer, MD, Dominique Jacques-Apostol, MD, Dominique Lauton, MD, Christéle Mestre, MD, Guy Costalat, MD, Claude Jaffiol, MD

Diabetes Care 1994;17(9):1064–1066

https://doi.org/10.2337/diacare.17.9.1064

Published: 01 September 1994

View article titled, Complications of the Pump Pocket May Represent a Significant Cause of Incidents With Implanted Systems for Intraperitoneal Insulin Delivery

Journal Articles

Intraperitoneal Insulin Administration Does Not Modify Plasminogen Activator Inhibitor 1 Levels in IDDM Patients

Denis Raccah, MD, Veronique Lassmann-Vague, MD, Marie-Christine Alessi, MD, Irene Juhan-Vague, MD, PHD, Philippe Vague, MD, PHD

Diabetes Care 1994;17(8):941–942

https://doi.org/10.2337/diacare.17.8.941b

Published: 01 August 1994

View article titled, Intraperitoneal Insulin Administration Does Not Modify Plasminogen Activator Inhibitor 1 Levels in IDDM Patients

Journal Articles

Insulin Antibody Responses After Long-Term Intraperitoneal Insulin Administration via Impiantatile Programmable Insulin Delivery Systems

Craig L Olsen, MD, Eve Chan, MS, Dee S Turner, MSN, Mohamed Iravani, BS, Maria Nagy, PHD, Jean-Louis Selam, MD, Nathan D Wong, PHD, Ken Waxman, MD, M Arthur Charles, MD, PHD

Diabetes Care 1994;17(3):169–176

https://doi.org/10.2337/diacare.17.3.169

Published: 01 March 1994

View article titled, Insulin Antibody Responses After Long-Term Intraperitoneal Insulin Administration via Impiantatile Programmable Insulin Delivery Systems

Journal Articles

Normalization of Lipoprotein Composition by Intraperitoneal Insulin in IDDM: Role of increased hepatic lipase activity

Giacomo Ruotolo, MD, Mariella Parlavecchia, PHD, Marja-Riitta Taskinen, MD, Gabriella Galimberti, MD, Adele Zoppo, MD, Ngoc-Anh Le, PHD, Francesca Ragogna, PHD, Piero Micossi, MD, Guido Pozza, MD

Diabetes Care 1994;17(1):6–12

https://doi.org/10.2337/diacare.17.1.6

Published: 01 January 1994

View article titled, Normalization of Lipoprotein Composition by Intraperitoneal Insulin in IDDM: Role of increased hepatic lipase activity

Journal Articles

Intraperitoneal Insulin Affects Insulin-Like Growth Factor Binding Protein-1 in a Well-Controlled Type I Diabetic Patient

Kathleen D Hopkins, MD, David L Russell-Jones, MRCP, Eldon D Lehmann, BSC, Michael J Wheeler, PHD, Peter H Sönksen, FRCP

Diabetes Care 1993;16(10):1404–1405

https://doi.org/10.2337/diacare.16.10.1404

Published: 01 October 1993

View article titled, Intraperitoneal Insulin Affects Insulin-Like Growth Factor Binding Protein-1 in a Well-Controlled Type I Diabetic Patient

Journal Articles

Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes

Jean-Louis Selam, MD, Piero Micossi, MD, Frederick L Dunn, MD, David M Nathan, MD, Implantable Insulin Pump Trial Study Group

Diabetes Care 1992;15(7):877–885

https://doi.org/10.2337/diacare.15.7.877

Published: 01 July 1992

View article titled, Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes

Journal Articles

Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic Patients

Jean-Louis Selam, MD, Denis Raccah, MD, Nathalie Jean-Didier, MD, Jim L Lozano, BS, Ken Waxman, MD, M Arthur Charles, MD, PHD

Diabetes Care 1992;15(1):53–58

https://doi.org/10.2337/diacare.15.1.53

Published: 01 January 1992

View article titled, Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic Patients

NARROW

Reversible Focal Hepatic Steatosis in Type 1 Diabetic Patients Treated With Intraperitoneal Insulin Implantable Pump Therapy

Comparison of Antigenicity of Hoechst 21PH Insulin Using Either Implantable Intraperitoneal Pump or Subcutaneous External Pump Infusion in Type 1 Diabetic Patients

Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.

Successful Treatment With Insulin Analog Lispro in IDDM With Delayed Absorption of Subcutaneously Applied Human Regular Insulin and Complicated Intraperitoneal Insulin Infusion: A case report

Acute Effects of Intraperitoneal Versus Subcutaneous Insulin Delivery on Glucose Homeostasis in Patients With NIDDM

Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps

Five Cases off Hyperthyroidism in Type I Diabetic Patients Treated With Intraperitoneal Insulin Infusion

Immunogenicity of Long-Term Intraperitoneal Insulin Administration With Implantable Programmable Pumps: Metabolic consequences

Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter study

Intraperitoneal Insulin Absorption After Lona-Term Intraperitoneal Insulin Therapy

Diagnostic Procedures for Catheter Malfunction in Programmable Impiantante Intraperitoneal Insulin Infusion Devices

Intraperitoneal Insulin Delivery Decreases the Levels of Chylomicron Remnants in Patients With IDDM

A Case of Diabetic Pregnancy Controlled With a Percutaneous Access Device for Intraperitoneal Insulin Infusion

Complications of the Pump Pocket May Represent a Significant Cause of Incidents With Implanted Systems for Intraperitoneal Insulin Delivery

Intraperitoneal Insulin Administration Does Not Modify Plasminogen Activator Inhibitor 1 Levels in IDDM Patients

Insulin Antibody Responses After Long-Term Intraperitoneal Insulin Administration via Impiantatile Programmable Insulin Delivery Systems

Normalization of Lipoprotein Composition by Intraperitoneal Insulin in IDDM: Role of increased hepatic lipase activity

Intraperitoneal Insulin Affects Insulin-Like Growth Factor Binding Protein-1 in a Well-Controlled Type I Diabetic Patient

Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes

Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic Patients

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only